SAVE THE DATE

3 downloads 180 Views 3MB Size Report
We are really honoured to host this wonderful meeting with such distin- guished guests from around the world. The meetin
EMSOS

2016

-

29TH

ANNUAL

MEETING

OF

THE

SAVE THE DATE

2016

25th, 26th, 27th May La Baule

La Baule Congress Center

FRANCE ORGANISING COMMITTEE:

Pr François Gouin (Nantes) Dr Françoise Rédini (Nantes) Dr Fabrice Fiorenza (Limoges)

WWW.EMSOS2016.COM

ORGANISATION

Benjamin Richier, Com&Co events 12, Bd Fellen - 13016 Marseille, France [email protected] • +33 (0)7 77 91 00 65

EDITORIAL

SAVE THE DATE EMSOS 2016 - 29TH ANNUAL MEETING OF THE

2016

25th, 26th, 27th May La Baule

La Baule Congress Center

FRANCE

• La Baule • Nantes

The local organising committee would like to warmly welcome you to the 29th annual meeting of the European Musculo Skeletal Oncology Society (EMSOS) and 17th EMSOS Nurse and allied professional Group Meeting which will be held at La Baule, France, 25th, 26th, 27th May 2016. We are really honoured to host this wonderful meeting with such distinguished guests from around the world. The meeting will be focussing on Ewing sarcoma, margins, pelvic tumors, targeted therapy; open sessions will offer the opportunity to report and discuss the latest results in all fields. The Congress venue is at La Baule which is located very near Nantes, in the heart of one of the most beautiful bays of Europe. La Baule offers high quality congress facilities combined with the quietness of an ocean beach resort. The organising Committee: Francois Gouin / Francoise Rédini / Fabrice Fiorenza

TOPICS •E  wing sarcoma “from bench to bedside”: fundamental research, preclinical models, new targeted therapy, micro-environment, multicenter clinical trials, radiation therapy, surgery •M  argins in sarcoma “definition, meaning, improving”: pathological view, surgical view, adequate margins, CAO, PSI, neo-adjuvant treatments •P  elvic bone tumours “multidisciplinary challenge”: resection, reconstruction, infection, oncologic outcome, functional outcome •T  argeted therapy: biological basis, GCT, PVNS, is it the future? what’s new? how does it change treatment strategy? Training day Free sessions Guest lectures

PARTNERS

WWW.EMSOS2016.COM